Micro Guided Catheter Market 2019 Global Overview by Industry Verticals: ASAHI INTECC, BOSTON SCIENTIFIC CORPORATION, CARDINAL HEALTH, COOK MEDICAL, INTEGER HOLDINGS CORPORATION

The global micro guided catheter market is expected to register a CAGR of about 7.6%, over the forecast period, 2018-2023. The steerable catheters have demonstrated many advantages to overcome the limitations of the conventional catheters in the minimally invasive surgery.

Get Sample Copy of this report @ https://marketprognosis.com/sample-request/17155

Technological Advancement
Remote controlled catheter navigation systems have recently been introduced into minimally invasive vascular surgery and some of them have already been applied in clinical practice. Steerable catheters with improved maneuverability play an important role in these innovations for conventional catheterization. The steerable catheters have demonstrated many advantages to overcome the limitations of the conventional catheters in the minimally invasive surgery. Steerable catheters are able to select direction in the distal end, and superior to conventional counterparts in many aspects. Differences between magnetic and active catheters mainly lie in function, safety, configuration of operating room and cost. They have similar requirements for miniaturization and slave insertion mechanisms. Steerable catheters are rapidly evolving and still require technological refinements to extend current capabilities. This will act as driver for the market growth in the forecast period. Other factors that will affect market growth positively include increase in adoption of minimally invasive surgeries,

Key Developments in the Market:
January 2017: FDA has granted Teleflex clearance to market its TrapLiner catheter, a device designed for use in accessing the peripheral and coronary vasculature along with guide catheters. The device comes with an integrated balloon to allow a standard 0.014-inch guide wire to be trapped inside a guide catheter

Major Players:
ASAHI INTECC CO., LTD, BOSTON SCIENTIFIC CORPORATION, CARDINAL HEALTH, COOK MEDICAL, INTEGER HOLDINGS CORPORATION, KONINKLIJKE PHILIPS N.V., MEDTRONIC PLC, MERIT MEDICAL SYSTEMS, INC., PENUMBRA, INC., AND TERUMO EUROPE NV, amongst others.

Enquiry Before Buying @ https://marketprognosis.com/enquiry/17155

Significant Product Recalls
Major companies, like Medtronic and Stryker are recalling their micro guide catheter products from the market. Strykeru2018s neurovascular division recalled for Boston Scientificu2018s Guider guide catheter it distributes over issues with an incomplete seal that could lead to blood loss. These factors affect the image of these products and hence the perception of user and healthcare providers towards the products. These will be detrimental to the growth micro guide catheters market and will act as a restraint for the market. Other factors that will act as restraints for the market include lack of reimbursement policies in emerging markets.

North America to Maintain Dominance
North America is the most attractive market in the viral inactivation industry and is expected to be the first preference for new entrants due to the increasing end-use in the region, followed by Europe. Asia-Pacific is the fastest growing market; hence the established players are focusing on the region.

Browse Report @ https://marketprognosis.com/report/global-micro-guided-catheter-market---segmented-by-product-type,-indication,-end-users,-and-geography---growth,-trends,-and-forecast-%282018---2023%29/pr-17155

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.